SciFluor Life Sciences, LLC - Product Pipeline Review - 2016

  • ID: 3960488
  • Company Profile
  • 32 pages
  • Global Markets Direct
1 of 5
SciFluor Life Sciences, LLC - Product Pipeline Review - 2016

The report ‘SciFluor Life Sciences, LLC - Product Pipeline Review - 2016’, provides an overview of the SciFluor Life Sciences, LLC’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by SciFluor Life Sciences, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of SciFluor Life Sciences, LLC
- The report provides overview of SciFluor Life Sciences, LLC including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses SciFluor Life Sciences, LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features SciFluor Life Sciences, LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate SciFluor Life Sciences, LLC’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for SciFluor Life Sciences, LLC
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding SciFluor Life Sciences, LLC’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Introduction

SciFluor Life Sciences, LLC Snapshot

SciFluor Life Sciences, LLC Overview

Key Facts

SciFluor Life Sciences, LLC - Research and Development Overview

Key Therapeutic Areas

SciFluor Life Sciences, LLC - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

SciFluor Life Sciences, LLC - Pipeline Products Glance

SciFluor Life Sciences, LLC - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

SciFluor Life Sciences, LLC - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

SciFluor Life Sciences, LLC - Drug Profiles

SF-0034 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SF-0166 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Dyskinesia - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Fibrosis - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Fungal Infections - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Infectious Diseases - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Inflammatory Diseases - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Neuroinflammation - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Pain - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule for Spasticity - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SciFluor Life Sciences, LLC - Pipeline Analysis

SciFluor Life Sciences, LLC - Pipeline Products by Target

SciFluor Life Sciences, LLC - Pipeline Products by Route of Administration

SciFluor Life Sciences, LLC - Pipeline Products by Molecule Type

SciFluor Life Sciences, LLC - Pipeline Products by Mechanism of Action

SciFluor Life Sciences, LLC - Dormant Projects

SciFluor Life Sciences, LLC - Locations And Subsidiaries

Head Office

List of Tables

SciFluor Life Sciences, LLC, Key Facts

SciFluor Life Sciences, LLC - Pipeline by Indication, 2016

SciFluor Life Sciences, LLC - Pipeline by Stage of Development, 2016

SciFluor Life Sciences, LLC - Monotherapy Products in Pipeline, 2016

SciFluor Life Sciences, LLC - Phase II, 2016

SciFluor Life Sciences, LLC - Preclinical, 2016

SciFluor Life Sciences, LLC - Discovery, 2016

SciFluor Life Sciences, LLC - Pipeline by Target, 2016

SciFluor Life Sciences, LLC - Pipeline by Route of Administration, 2016

SciFluor Life Sciences, LLC - Pipeline by Molecule Type, 2016

SciFluor Life Sciences, LLC - Pipeline Products by Mechanism of Action, 2016

SciFluor Life Sciences, LLC - Dormant Developmental Projects,2016

List of Figures

SciFluor Life Sciences, LLC - Pipeline by Top 10 Indication, 2016

SciFluor Life Sciences, LLC - Pipeline by Stage of Development, 2016

SciFluor Life Sciences, LLC - Monotherapy Products in Pipeline, 2016

SciFluor Life Sciences, LLC - Pipeline by Target, 2016

SciFluor Life Sciences, LLC - Pipeline by Molecule Type, 2016

SciFluor Life Sciences, LLC - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Theranexus SAS
- Vichem Chemie Research Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll